Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria Vaccine

NCT00164411 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

FED

Sponsor class

Conditions

Pneumococcal Infections

Interventions

BIOLOGICAL: Tetanus-diphtheria toxoids (Td)
BIOLOGICAL: 7-valent pneumococcal conjugate vaccine
BIOLOGICAL: 23-valent polysaccharide vaccine

Sponsor

Centers for Disease Control and Prevention

Collaborators

[object Object]